A Phase II Study to Evaluate the Safety, Pharmacodynamics, and Efficacy of Entinostat in Combination with Nivolumab plus Ipilimumab in Patients with Renal Cell Carcinoma Previously Treated with Nivolumab plus Ipilimumab

Learn more:

• https://clinicaltrials.gov/study/NCT03552380
• News release

Study Contact: studies@hoosiercancer.org; (317) 921-2050.